VisionGate

About:

VisionGate offers an automated 3D cell imaging platform that saves lives through early cancer detection and prevention.

Website: http://visiongate3d.com

Twitter/X: visiongate3d

Top Investors: Trinnovate Ventures

Description:

VisionGate is dedicated to saving lives through early cancer detection and prevention, utilizing its revolutionary automated 3D cell imaging platform that is capable of generating high-resolution 3D biosignatures from intact cells. It is a clinical-stage oncology pharmaceutical and diagnostics company. Their lead diagnostic product is the LuCED lung test - a non-invasive sputum-based test that detects abnormal cells which indicate lung cancer and bronchial dysplasia. It was founded by Alan Nelson and is based in Phoenix, Arizona.